We used two prostate cancer cell lines (MDA-PCa-2b and PC3) harboring co-overexpression of ETV1 and ETV4 to gain insight into their biological role in vitro, and found both specific and shared candidate target genes that may play a role in tumor aggressiveness in vivo. Here, ETV4 is linked to prostate cancer.